MIHIR BHATTA

Dr. MIHIR BHATTA

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
MBMIHIR BHATTA
MIHIR BHATTA
SNSrijita Nandi
Srijita Nandi
SDShanta Dutta
Shanta Dutta
DSDr Moloy Saha
Dr Moloy Saha
COVID-19 is an international public health emergency in need of effective and safe vaccines for SARS-CoV-2. A systematic review has been done to analyze the availability, development and status of new COVID-19 vaccine candidates as well as the status of vaccines for other diseases that might be effective against SARS-CoV-2 infection. PubMed, MEDLINE, EMBASE, Science Direct, Google Scholar, Cochrane library, ClinicalTrials.gov, Web of Science and different trial registries were searched for currently available and probable future vaccines. Articles and ongoing clinical trials are included to ascertain the availability and developmental approaches of new vaccines that could limit the present and future outbreaks. Pharmaceutical companies and institutions are at different stages of developing new vaccines, and extensive studies and clinical trials are still required.

13 March 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MBMIHIR BHATTA
MIHIR BHATTA
AMAgniva Majumdar
Agniva Majumdar
UGUtsha Ghosh
Utsha Ghosh
PGPiyali Ghosh
Piyali Ghosh
PBPapiya Banerji
Papiya Banerji
SDShanta Dutta
Shanta Dutta
Background: Sexually transmitted infections (STIs) are one of the leading causes of health, and economic burdens in the developing world, leading to considerable morbidity, mortality, and stigma. The incidence and prevalence of the four curable STIs viz. syphilis, gonorrhoea, chlamydia, and trichomoniasis vary remarkably across different geographical locations. In India, the prevalence of four curable STI among general populations is in between 0 to 3.9 percent. However, it is assumed that STI prevalence is much higher among subpopulations practicing high-risk behaviour. Like men who have sex with men (MSM), transgender (TG), injecting drug users (IDU), and female sex workers (FSW). Objectives: In the present circumstances, a systematic review is necessary to integrate the available data from previously published peer-reviewed articles and published reports from several competent authorities to provide the prevalence and geographical distribution of the four curable STIs among the key population of India. Methods: All available articles will be retrieved from PubMed, Google Scholar, Cochrane database, Scopus, Science Direct, and the Global Health network using the appropriate search terms. The data will be extracted through data extraction form as per PICOS (population, intervention, comparison, outcome, study design) framework. Risk of bias and quality assessment will be performed according to the situation with the help of available conventional protocol. Discussion: The future systematic review, generated from the present protocol, may provide evidence of the prevalence and geographical distribution of the four curable STIs among the key population of India. We hope that the findings of the future systematic review will strengthen the existing surveillance system in India, to determine the above-mention STIs prevalence among key populations in India. Protocol registration number: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42022346470.

1 January 2014 in IOSR Journal of Pharmacy and Biological Sciences
Verified
Journal Article
Closed access
MBMIHIR BHATTA
MIHIR BHATTA
DDDebasish Das
Debasish Das
PGProbalRanjan Ghosh
ProbalRanjan Ghosh

5 December 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MBMIHIR BHATTA
MIHIR BHATTA
AMAgniva Majumdar
Agniva Majumdar
UGUtsha Ghosh
Utsha Ghosh
PGPiyali Ghosh
Piyali Ghosh
PBPapiya Banerji
Papiya Banerji
SDShanta Dutta
Shanta Dutta
Background Sexually transmitted infections (STIs) are one of the leading causes of health, and economic burdens in the developing world, leading to considerable morbidity, mortality, and stigma. The incidence and prevalence of the four curable STIs viz syphilis, gonorrhoea, chlamydia, and trichomoniasis vary remarkably across different geographical locations. In India, the prevalence of four curable STI among general populations is in between 0 to 3.9 per cent. However, it is assumed that STI prevalence is much higher among subpopulations practicing high-risk behaviour. Like men who have sex with men (MSM), transgender (TG), injecting drug users (IDU) and female sex worker (FSW). Objectives In the present circumstances, a systematic review is necessary to integrate the available data from previously published peer-reviewed articles and published reports from several competent authorities to provide the prevalence and geographical distribution of the four curable STIs among the key population of India. Methods All available articles will be retrieved from PubMed, Google Scholar, Cochrane database, Scopus, Science Direct, and the Global Health network using the appropriate search terms. The data will be extracted through data extraction form as per PICOS (population, intervention, comparison, outcome, study design) framework. Risk of bias and quality assessment will be performed with the help of the Funnel plot and Newcastle - Ottawa Quality Assessment Scale. Conclusion The future systematic review, which will be generated from the present protocol, may provide evidence of the prevalence and geographical distribution of the four curable STIs among the key population of India. The findings of the future systematic review will strengthen the existing surveillance system in India, to determine the above-mention STIs prevalence among key populations in India. Protocol registration number International Prospective Register for Systematic Reviews (PROSPERO) number CRD42022346470

2 October 2024 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
SBSitikantha Banerjee
Sitikantha Banerjee
KBKajari Bandyopadhyay
Kajari Bandyopadhyay
DCDebjit Chakraborty
Debjit Chakraborty
MBMIHIR BHATTA
MIHIR BHATTA

19 June 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
MBMIHIR BHATTA
MIHIR BHATTA
AMAgniva Majumdar
Agniva Majumdar
SBSitikantha Banerjee
Sitikantha Banerjee
PGPiyali Ghosh
Piyali Ghosh
SBSubrata Biswas
Subrata Biswas
SDShanta Dutta
Shanta Dutta
Background: Respondent-driven sampling (RDS) is a nonprobability sampling technique that allows the extrapolation of its outcome to the target population. This approach is typically used to overcome the difficulties in studying hidden or difficult-to-reach groups. Objective: The purpose of this protocol is to generate a systematic review on the accumulation of biological and behavioral data of female sex workers (FSWs) through different surveys that use the RDS method from around the world in the near future. The future systematic review will discuss the initiation, actualization, and problems of RDS during the accumulation of biological and behavioral data of FSWs through surveys from around the world. Methods: The behavior and biological data of FSWs will be extracted from peer-reviewed studies published between 2010 and 2022 and that are acquired through RDS. Using PubMed, Google Scholar, the Cochrane database, Scopus, Science Direct, and the Global Health network, all papers that are available will be obtained using the search phrases “respondent-driven” and “Female Sex Workers” OR “FSW” OR “sex workers” OR “SW.” According to STROBE-RDS (Strengthening the Reporting of Observational Studies in Epidemiology for Respondent-Driven Sampling) criteria, the data will be retrieved through a data extraction form and will be organized using World Health Organization classifications of areas. The Newcastle-Ottawa Quality Assessment Scale will be used to measure bias risk and overall study quality. Results: The future systematic review that will be generated from this protocol will offer evidence for or against the claim that using the RDS technique to recruit participants from “hidden” or “hard-to-reach” populations is the best strategy. The results will be disseminated through a peer-reviewed publication. Data collection started on April 1, 2023, and the systematic review is expected to be published by December 15, 2023. Conclusions: A minimum set of parameters for specific methodological, analytical, and testing procedures, including RDS methods to evaluate the overall quality of any RDS survey, will be provided by the future systematic review, in accordance with this protocol, to assist researchers, policy makers, and service providers in improving RDS methods for the surveillance of any key population. Trial Registration: PROSPERO CRD42022346470; https://tinyurl.com/54xe2s3k International Registered Report Identifier (IRRID): DERR1-10.2196/43722